Health Care & Life Sciences » Pharmaceuticals | AVEO Pharmaceuticals Inc.

AVEO Pharmaceuticals Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
119,104.00
55,303.00
34,135.00
23,348.00
33,525.00
24,427
Total Accounts Receivable
6,817.00
2,341.00
4,641.00
1,027.00
402.00
3,026
Other Current Assets
2,998.00
1,484.00
1,600.00
1,940.00
16,256.00
482
Total Current Assets
128,919.00
59,128.00
40,376.00
26,315.00
50,183.00
27,935
Net Property, Plant & Equipment
14,140.00
11,295.00
23.00
-
-
-
Total Investments and Advances
2,997.00
-
-
-
-
-
Other Assets
290.00
239.00
143.00
970.00
15.00
-
Total Assets
146,346.00
70,662.00
40,542.00
27,285.00
50,198.00
27,935
ST Debt & Current Portion LT Debt
10,383.00
11,722.00
2,053.00
2,124.00
-
Accounts Payable
4,238.00
3,245.00
1,425.00
2,186.00
2,436.00
Other Current Liabilities
16,787.00
25,388.00
8,920.00
6,039.00
29,688.00
Total Current Liabilities
31,408.00
40,355.00
12,398.00
10,349.00
32,124.00
Long-Term Debt
8,822.00
8,930.00
7,418.00
11,879.00
18,477.00
Other Liabilities
36,178.00
771.00
3,499.00
6,980.00
40,360.00
Total Liabilities
76,408.00
50,056.00
23,315.00
29,208.00
90,961.00
Common Equity (Total)
69,938.00
20,606.00
17,227.00
1,923.00
40,763.00
Total Shareholders' Equity
69,938.00
20,606.00
17,227.00
1,923.00
40,763.00
Total Equity
69,938.00
20,606.00
17,227.00
1,923.00
40,763.00
Liabilities & Shareholders' Equity
146,346.00
70,662.00
40,542.00
27,285.00
50,198.00

About AVEO Pharmaceuticals

View Profile
Address
One Broadway
Cambridge Massachusetts 02142
United States
Employees -
Website http://www.aveooncology.com
Updated 07/08/2019
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380, and AV-353. The company was founded by Ronald A.